MONOPAR THERAPEUTICS INC (MNPR:NASDAQ)
$113.72 2.9 (2.6169%)
Analysed MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) News Sources
Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026
19-04-2026
yahoo.com
Monopar Therapeutics (NASDAQ:MNPR) Is In A Good Position To Deliver On Growth Plans
03-05-2026
yahoo.com
Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
14-05-2026
yahoo.com
Monopar Announces Publication of Phase 2 Study Demonstrating ALXN1840 Significantly Improves Copper Balance in Patients with Wilson Disease
19-05-2026
yahoo.com
Monopar Presents Phase 2 ALXN1840 Data Demonstrating Liver Disease Stabilization and Neurologic Improvement in Treatment-Experienced Wilson Disease Patients at EASL 2026
01-06-2026
yahoo.com
Wall Street Analysts Believe Monopar Therapeutics (MNPR) Could Rally 88.92%: Here's is How to Trade
15-06-2026
yahoo.com
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease
26-06-2026
yahoo.com
Monopar Advances Launch Readiness with Addition of Veteran Commercial Executive Nicole Sweeny to Board of Directors and Expansion of Commercial Leadership Team
20-07-2026
yahoo.com
Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease
22-07-2026
yahoo.com
Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
12-08-2026
yahoo.com
What is the current price of MONOPAR THERAPEUTICS INC (MNPR:NASDAQ)?
The current price of MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) is $113.72.
MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) absolute price change since previous trading day?
The absolute price change of MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) since the previous trading day is $2.9.
MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) percentage price change since previous trading day?
The percentage price change of MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) since the previous trading day is 2.6169%.
What is the most recent average sentiment score for MONOPAR THERAPEUTICS INC (MNPR:NASDAQ)?
The most recent average sentiment score for MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for MONOPAR THERAPEUTICS INC (MNPR:NASDAQ)?
The most recent sentiment for MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) is .
SEC-8K** Filing Available For MONOPAR THERAPEUTICS INC (MNPR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.